Role for polo-like kinase 4 in mediation of cytokinesis | PNAS
Rabbit anti-Human PLK4 antibody (ABIN2682502)
Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research
The Role of Polo-like Kinase 1 in Carcinogenesis: Cause or Consequence? | Cancer Research
PLK Inhibition | PLK Activation | PLK Inhibitor Review
Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research
Functions of Polo-Like Kinases: A Journey From Yeast To Humans | Bentham Science
Goat anti-Human PLK4 antibody (ABIN184701)
PLOS ONE: Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor Prognosis
Polo-like Kinase 4 Autodestructs by Generating Its Slimb-Binding Phosphodegron - ScienceDirect
Goat anti-Human PLK4 antibody (ABIN184701)
Polo-like Kinase 4 Inhibition: A Strategy for Cancer Therapy? - ScienceDirect
Polo-like kinase inhibitors in hematologic malignancies - ScienceDirect
Targeting Polo-like Kinase in Cancer Therapy | Clinical Cancer Research
Figure 2 from Polo-like kinase 4: the odd one out of the family | Semantic Scholar
Autoinhibition and relief mechanism for Polo-like kinase 4 | PNAS
Transient changes in the levels of polo-like kinase (Plk) 4 and... | Download Scientific Diagram
Targeting polo-like kinase 1 for cancer therapy | Nature Reviews Cancer
APExBIO - CFI-400945 orally available, selective inhibitor of polo-like kinase 4 (PLK4) | CAS# 1338800-06-8
Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment - ScienceDirect
Polo-like Kinase 4 Shapes Up - ScienceDirect
PDF) Polo-like kinase 4 activity limits centrosome overduplication by autoregulating its own stability
